London’s Guardian Features Special Supplement Examining Access to AIDS Drugs in Sub-Saharan Africa
London's Guardian today features a special investigation into "the people with the money, power and influence to save" the lives of the nearly 30 million people in sub-Saharan Africa who do not have access to HIV/AIDS medications. The special supplement, titled "Saving Grace," asks the question: "[W]hy can the poor not get the drugs to live with AIDS when the rich can?" The main feature of the section is interviews with people who live and work on the forefront of the fight against HIV/AIDS, including: Grace Matnanga, an HIV-positive shoe seller for whom the series is named; Athenase Kiromera, a doctor who works in a hospital in Malawi; Justin Malewezi, Malawi's vice president who runs the country's campaign against AIDS; Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria; Yusuf Hamied, chief of Cipla, an Indian generic drug producer; Harvey Bale, head of the International Federation of Pharmaceutical Manufacturers Associations; Graham Dukes, professor of pharmacotherapy at the University of Oslo in Norway; and Jean Pierre Garnier, head of GlaxoSmithKline. In addition, the section features several articles on drug access, as well as an online chat today with Sarah Boseley, Guardian health editor, and a member of Medecins Sans Frontieres (Guardian Web site, 2/18). The special report is available online.This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.